Title: Drugs for preventing red blood cell dehydration in people with sickle cell disease.
Journal: The Cochrane database of systematic reviews20120711
Title: Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma.
Journal: Journal of signal transduction20120101
Title: Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease.
Journal: International journal of Alzheimer's disease20120101
Title: Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia.
Journal: British journal of haematology20111201
Title: Senicapoc trial results support the existence of different sub-phenotypes of sickle cell disease with possible drug-induced phenotypic shifts.
Journal: British journal of haematology20111201
Title: Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
Journal: British journal of haematology20110401
Title: Drugs for preventing red blood cell dehydration in people with sickle cell disease.
Journal: The Cochrane database of systematic reviews20100120
Title: Hypoxia activates a Ca2+-permeable cation conductance sensitive to carbon monoxide and to GsMTx-4 in human and mouse sickle erythrocytes.
Journal: PloS one20100101
Title: Promising therapies in sickle cell disease.
Journal: Cardiovascular & hematological disorders drug targets20090301
Title: Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia.
Journal: Expert opinion on investigational drugs20090201
Title: Pathophisiology of sickle cell disease and new drugs for the treatment.
Journal: Mediterranean journal of hematology and infectious diseases20090101
Title: Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.
Journal: Blood20080415
Title: Gardos pathway to sickle cell therapies?
Journal: Blood20080415
Title: Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
Journal: Journal of medicinal chemistry20080227
Title: Dose-escalation study of ICA-17043 in patients with sickle cell disease.
Journal: Pharmacotherapy20061101
Title: Investigational agents for sickle cell disease.
Journal: Expert opinion on investigational drugs20060801
Title: Current therapy of sickle cell disease.
Journal: Haematologica20060101
Title: [Clinical trials of new therapeutic pharmacology for sickle cell disease].
Journal: Sante (Montrouge, France)20060101
Title: New therapies for sickle cell disease.
Journal: Hematology/oncology clinics of North America20051001
Title: ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.
Journal: Blood20030315
Title: Stocker JW, et al. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood. 2003 Mar 15;101(6):2412-8.
Title: Van Der Velden J, et al. K(Ca)3.1 channel-blockade attenuates airway pathophysiology in a sheep model of chronic asthma. PLoS One. 2013 Jun 24;8(6):e66886.
